Eye mounted device for therapeutic agent release
US-12167978-B2 · Dec 17, 2024 · US
US10603382B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10603382-B2 |
| Application number | US-201916565983-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 10, 2019 |
| Priority date | Oct 31, 2014 |
| Publication date | Mar 31, 2020 |
| Grant date | Mar 31, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to ophthalmic compositions for treatment of conditions in the eye. More specifically, the present invention relates to ophthalmic compositions comprising a polyquaternium compound and an anionic polymer. Methods for reducing and/or preventing the incompatibility of polyquaternium compounds with anionic polymers are also disclosed.
Opening claim text (preview).
What is claimed is: 1. A composition comprising: a. from about 10 ppm to about 1000 ppm of a polyquaternium compound having a weight average molecular weight of from about 150 to about 15,000 Daltons; b. from about 0.001% to about 0.5% of an anionic polymer having a weight average molecular weight of from about 250 to about 4,000,000 Daltons; and c. an effective amount of an organic acid, salts thereof or mixtures thereof, such that the organic acid binds with the polyquaternium compound at at least a 1:1 molar ratio; wherein the composition is substantially free of cationic oligomer compounds and precipitation inhibiting compounds and further wherein the composition is in the form of a spray or mist and is ophthalmically suitable for application to a subject's eye. 2. The composition of claim 1 wherein the polyquaternium compound has weight average molecular weight of from about 200 to about 13,500 Daltons. 3. The composition of claim 2 wherein the polyquaternium compound is selected from the group consisting of polyquatemium-1, polyquaternium-10, polyquaternium-42 or mixtures thereof. 4. The composition of claim 3 wherein the polyquaternium compound is polyquaternium-42. 5. The compositions of claim 1 wherein the anionic polymer has a weight average molecular weight of from about from about 100,000 to about 3,000,000 Daltons. 6. The composition of claim 5 wherein the anionic polymer is selected from the group consisting of alginates; carageenans; carbomers, high molecular weight, non-linear polyacrylic acid cross-linked with polyalkenyl polyethers; sodium carboxymethylcellulose; internally cross-linked sodium carboxymethylcelluloses; gellan gum; hyaluronic acid; pectin; xanthan gum; alkylvinyl ether/maleic anhydride copolymer; and mixtures of thereof. 7. The composition of claim 6 wherein the anionic polymer is selected from the group consisting of hyaluronic acid, gellan gum, alkylvinyl ether/maleic anhydride copolymer and mixtures thereof. 8. The composition of claim 7 wherein the anionic polymer is hyaluronic acid. 9. The composition of claim 7 wherein the anionic polymer is gellan gum. 10. The composition of claim 7 wherein the anionic polymer is an alkyl vinyl ether/maleic anhydride copolymer. 11. The composition of claim 10 wherein the anionic polymer is a free acid of alkyl vinyl ether/maleic anhydride copolymer. 12. The composition of claim 1 wherein the organic acid is selected from the group consisting of carboxylic acids, dicarboxylic acids, tricarboxylic acids and mixtures thereof. 13. The composition of claim 12 wherein the organic acid is a carboxylic acid. 14. The composition of claim 13 wherein the carboxylic acid is selected from the group consisting of formic acid, acetic acid, propionic acid, salts thereof, and mixtures thereof. 15. The composition of claim 12 wherein the organic acid is a dicarboxylic acid. 16. The composition of claim 15 wherein the dicarboxylic acid is selected from the group consisting of glutaric acid, maleic acid, tartaric acid, salts thereof, and mixtures thereof. 17. The composition of claim 16 wherein the dicarboxylic acid is tartaric acid. 18. The composition of claim 12 wherein the organic acid is a tricarboxylic acid. 19. The composition of claim 18 wherein the tricarboxylic acid is selected from the group consisting of citric acid, isocitric acid, aconitic acid, trimesic acid, propane-1,2,3-tricarboxylic acid and mixtures thereof. 20. The composition of claim 19 wherein the tricarboxylic acid is citric acid.
Celluloses · CPC title
Hyaluronic acid · CPC title
Ophthalmic agents · CPC title
Eye, e.g. artificial tears · CPC title
of acrylic acid or derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.